Progenics Pharmaceuticals Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Progenics Pharmaceuticals (NASDAQ:PGNX) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.85 EPS
Next Year EPS Consensus Estimate: $-0.4 EPS
Progenics Pharmaceuticals (NASDAQ PGNX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)